The Precision Peptide Company Inc. PNGAF
0.19 USD +0.01 (+3.99%)
At closeNov 10, 2026, 4:00 PM EST
0.18 Day range 0.1921
0.0077 52-week range 0.4099
- YTD
- -9.27%
- 1 year
- -24.12%
Financial health
Altman Z-Score
-3.96 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -1.9×
FY 2021 5y median -2.9× FY 2025
P/S 177×
FY 2021 5y median 24.5× FY 2025
P/B 9.4×
FY 2021 5y median 9.4× FY 2025
P/FCF -3.8×
FY 2021 5y median -4.8× FY 2025
EV/EBITDA -3.6×
FY 2021 5y median -3.6× FY 2025
EV/Sales 157×
FY 2021 5y median 16.4× FY 2025
FCF Yield -26.5%
FY 2021 5y median -20.7% FY 2025
Profitability
Gross Margin -139.1%
FY 2021 5y median -11.5% FY 2025
Operating Margin -4530.1%
FY 2021 5y median -575.4% FY 2025
Net Margin -9104.5%
FY 2021 5y median -581.4% FY 2025
ROE -486.9%
FY 2021 5y median -14.1% FY 2025
ROIC -242.3%
FY 2021 5y median -14.1% FY 2025
ROA -340.1%
FY 2021 5y median -340.1% FY 2025
Growth (YoY)
Revenue 307.4%
FY 2021 FY 2025
Operating Income -144.6%
FY 2021 FY 2025
EPS (diluted) -40.0%
FY 2021 FY 2025
Free Cash Flow -429.9%
FY 2021 FY 2025
Financial Health
Current Ratio 3.3×
FY 2021 5y median 1.4× FY 2025
Quick Ratio 3.1×
FY 2021 5y median 1.2× FY 2025
Debt / Equity 0.0×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA 0.4×
FY 2021 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2021 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-10-31